Insomnia Chronic: Clinical Trials

4 trials for Insomnia Chronic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 withdrawn. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Active not recruiting 1, Withdrawn 1

Follow Insomnia Chronic: new trials by email Literature Review of Insomnia Chronic trials Research Report on Insomnia Chronic

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients with Severe Insomnia
Chloral Hydrate - Insomnia, Insomnia Chronic
Phase 4CompletedPharmanovia1002023-09-012024-11-07
Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept
Pimavanserin - Insomnia Chronic, Posttraumatic Stress Disorder
Phase 4WithdrawnBaylor College of Medicine2022-12-152023-03-24
Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial
Fisher Wallace Neurostimulation Device - Insomnia, Insomnia Chronic
Phase 4Active not recruitingProofPilot2002020-10-012021-01-14
Partial Reinforcement II: Three Approaches to Maintenance Therapy for Chronic Insomnia
Zolpidem tartrate - Insomnia, Insomnia Chronic
Phase 4CompletedUniversity of Pennsylvania1972019-04-152025-05-09

Narrower conditions

Sleep Initiation and Maintenance Disorders (4)  ·  Stress Disorders, Post-Traumatic (1)

Broader conditions

Dyssomnias (4)  ·  Mental Disorders (4)  ·  Nervous System Diseases (4)  ·  Sleep Disorders, Intrinsic (4)  ·  Sleep Wake Disorders (4)  ·  Stress Disorders, Traumatic (1)  ·  Trauma and Stressor Related Disorders (1)

Interventions

Chloral Hydrate (1)  ·  Zolpidem (1)  ·  pimavanserin (1)

Sponsors

Baylor College of Medicine (1)  ·  Pharmanovia (1)  ·  ProofPilot (1)  ·  University of Pennsylvania (1)

Countries

United States (3)  ·  United Kingdom (1)

Top investigators

Melissa B Jones, MD (1)  ·  Michael L Perlis, PhD (1)

Results publications

PMID 42199304

NIH funding

R01AG054521 (1)